Delcath Liver Chemotherapy Delivery System PMA Anticipated In 2003
This article was originally published in The Gray Sheet
Executive Summary
Delcath Systems, Inc. appears on track to submit a premarket approval application to FDA for its Delcath liver chemotherapy drug delivery system in 2003. A pivotal Phase III trial is scheduled to begin in the current quarter.